Scientific Program

 

Scientific Program


EHA-SWG Scientific Meeting on Shaping the Future of Mesenchymal Stromal Cells Therapy

 

Thursday, November 23, 2017

14:00 - 14:15 Opening ceremony

Chair: WE Fibbe (The Netherlands)

14:15 - 15:45 SCIENTIFIC SESSION

Tissue specificity of stromal cells

Tissue specificity of stromal cells

Chair: F Dazzi (United Kingdom)

  • Stromal cells in the hematopoietic niche
    S Mendez Ferrer (United Kingdom)
  • Diversity of stromal cells in the skin
    F Watt (United Kingdom)
  • The role of mesenchymal inflammation in leukemia evolution
    M Raaijmakers (The Netherlands)
15:45 - 16:15 Coffee break

16:15 - 17:30 ABSTRACT SESSION

Chair: F Dazzi (United Kingdom)

  • Titles and speakers to be announced

17:30 - 18:00 CASE SESSION

Chair: F Dazzi (United Kingdom)

  • Titles and speakers to be announced

18:00 - 19:00 Welcome reception

 

Friday, November 24, 2017

09:00 - 10:30 SCIENTIFIC SESSION

Chair: WE Fibbe (The Netherlands)

MSC and the tumor microenvironment

Tumor stromal cells
Speaker to be announced
The biology of inflamation
Speaker to be announced
Tumor associated macrophages
V Bronte (Italy)
  • Tumor stromal cells
    J Shields (United Kingdom)
  • The biology of inflammation
    T Lawrence (France)
  • Role of myeloid-derived suppressor cells in cancer immune evasion
    V Bronte (Italy)

10:30 - 11:00 Coffee break

11:00 - 12:30 SCIENTIFIC SESSION

Chair: WE Fibbe (The Netherlands)

Product development

  • Empowering the immune system by MSC
    Y Shi (China)
  • Potency assays development
    K Schepers (The Netherlands)
  • Biomarker signature
    A Galleu (United Kingdom)

12:30 - 14:00 Lunch

14:00 - 16:00 SCIENTIFIC SESSION

Chair: WE Fibbe (The Netherlands)

Clinical trials

  • Allogeneic adipose-derived MSC for complex perianal fistulas in Crohn’s disease
    Speaker to be announced
  • MSC in organ transplantation
    AJ Rabelink (The Netherlands)
  • Mesenchymal stromal cells for Graft-versus-Host Disease
    M Bornhäuser (Germany)
  • MSC in therapeutic perspective
    WE Fibbe (The Netherlands)

16:00 - 16:30 Coffee break

16:30 - 17:30 ABSTRACT SESSION

Chair: WE Fibbe (The Netherlands)

  • Titles and speakers to be announced

17:30 - 18:00 INTERACTIVE PANEL DISCUSSION

Towards MSC as a standard of care, where do we stand?

Chair: WE Fibbe (The Netherlands)

  • Speakers to be announced

Saturday, November 25, 2017

09:00 - 10:30 SCIENTIFIC SESSION

Chair: D Niederwieser (Germany)

Clinical issues

Is global harmonization of ATMP guidelines possible?
Speaker to be announced
Ethical considerations on randomized clinical trials with MSC’s
K Hug (Sweden)
Academic or commercial production of MSC
F Luyten (Belgium
  • Is global harmonization of ATMP guidelines possible?
    P Hurley (United Kingdom)
  • Ethical considerations on randomized clinical trials with MSC’s
    K Hug (Sweden)
  • Academic or commercial production of MSC
    FPL Luyten (Belgium)

10:30 - 11:00 Coffee break

11:00 - 11:45 INTERACTIVE PANEL DISCUSSION

Chair: D Niederwieser (Germany)

Regulatory and ethical hurdles in clinical trials using MSC, how can they be solved?

  • Speakers to be announced
11:45 - 12:45 ABSTRACT SESSION

Chair: D Niederwieser (Germany)

  • Titles and speakers to be announced

12:45 - 13:00 Closing ceremony

Chair: F Dazzi (United Kingdom)

13:00 - 14:00 Lunch